Community Health Systems, Inc.
CYH · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 12.21B | 4.91B | 821.00M | 46.00M | 0.36 |
| 2023 FY | 12.49B | 5.08B | 957.00M | -133.00M | -1.02 |
| 2024 FY | 12.63B | 5.27B | 542.00M | -516.00M | -3.90 |
| 2025 FY | 12.49B | 1.08B | -9.92B | 509.00M | 3.80 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 14.67B | 15.40B | 118.00M | 12.39B | -1.37B |
| 2023 FY | 14.46B | 15.28B | 38.00M | 12.17B | -1.39B |
| 2024 FY | 14.05B | 15.37B | 37.00M | 12.10B | -1.91B |
| 2025 FY | 13.20B | 14.04B | 260.00M | 11.58B | -1.39B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 300.00M | -415.00M | -115.00M | — | -389.00M |
| 2023 FY | 210.00M | -467.00M | -257.00M | — | -80.00M |
| 2024 FY | 480.00M | -360.00M | 120.00M | — | -1.00M |
| 2025 FY | 543.00M | -335.00M | 208.00M | — | 223.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 556.45M | 12.83B | — | — | — |
| 2023 FY | 408.13M | 12.54B | — | — | — |
| 2024 FY | 394.98M | 12.46B | — | — | — |
| 2025 FY | 418.08M | 11.74B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 3.13B | 1.34B | 512.00M | 282.00M | 2.11 |
| 2025 Q3 | 3.09B | 2.63B | 243.00M | 130.00M | 0.97 |
| 2025 Q4 | 3.11B | -4.18B | -10.95B | 110.00M | 0.82 |
| 2026 Q1 | 12.16B | 11.75B | 1.64B | -610.00M | -4.57 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 13.64B | 14.74B | 456.00M | 11.49B | -1.63B |
| 2025 Q3 | 13.24B | 14.19B | 123.00M | 11.24B | -1.50B |
| 2025 Q4 | 13.20B | 14.04B | 260.00M | 11.58B | -1.39B |
| 2026 Q1 | 13.18B | 14.15B | 712.00M | 10.76B | -1.45B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 88.00M | -91.00M | -3.00M | — | 25.00M |
| 2025 Q3 | 69.00M | -65.00M | 4.00M | — | -333.00M |
| 2025 Q4 | 266.00M | -94.00M | 172.00M | — | 137.00M |
| 2026 Q1 | -297.00M | -76.00M | -373.00M | — | 452.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 455.60M | 11.49B | — | — | — |
| 2025 Q3 | 426.93M | 11.55B | — | — | — |
| 2025 Q4 | 418.08M | 11.74B | — | — | — |
| 2026 Q1 | 393.96M | 10.44B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |